January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

As seen during the COVID-19 pandemic, bottlenecks can occur at various stages of the vaccine supply chain, including shortages of vaccine ingredients, packaging materials, and fill-and-finish ...